Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | January 16, 2014 |
| Target | BioFire Diagnostics |
| Sector | Medical Products |
| Buyer(s) | bioMerieux |
| Deal Type | Add-on Acquisition |
| Deal Value | 450M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1963 |
| Sector | Life Science |
| Employees | 14,147 |
| Revenue | 4.0B EUR (2024) |
bioMerieux is a provider in the field of in vitro diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening, monitoring, and cardiovascular emergencies. bioMerieux was founded in 1963 and is based in Marcy-l'Étoile, France.
| Deal Context for Buyer | # |
|---|---|
| Overall | 15 of 21 |
| Sector: Medical Products | 5 of 9 |
| Type: Add-on Acquisition | 12 of 17 |
| State: Utah | 1 of 1 |
| Country: United States | 6 of 8 |
| Year: 2014 | 1 of 2 |
| Size (of disclosed) | 1 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-07-19 |
Argene SA
Verniolle, France Argene SA is a specialized in molecular diagnostics company. |
Buy | €38M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-10-22 |
Advencis Sarl
Mutzig, France Advencis Sarl are an innovative company in instrumentation for the Life Sciences & Healthcare sectors. Company focus is on developing innovative and easy-to-use products for customers that deliver highly valued benefits to final users. |
Buy | - |
